Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases
We have previously published a study on the reliable detection of 2-hydroxyglutarate (2HG) in lower-grade gliomas by magnetic resonance spectroscopy (MRS). In this short article, we re-evaluated five glioma cases originally assessed as isocitrate dehydrogenase (IDH) wildtype, which showed a high acc...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/02c8ce6392cb47eda48b441c0572e5df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:02c8ce6392cb47eda48b441c0572e5df |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:02c8ce6392cb47eda48b441c0572e5df2021-11-25T17:21:51ZDetection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases10.3390/diagnostics111121292075-4418https://doaj.org/article/02c8ce6392cb47eda48b441c0572e5df2021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2129https://doaj.org/toc/2075-4418We have previously published a study on the reliable detection of 2-hydroxyglutarate (2HG) in lower-grade gliomas by magnetic resonance spectroscopy (MRS). In this short article, we re-evaluated five glioma cases originally assessed as isocitrate dehydrogenase (IDH) wildtype, which showed a high accumulation of 2HG, and were thought to be false-positives. A new primer was used for the detection of <i>IDH2</i> mutation by Sanger sequencing. Adequate tissue for DNA analysis was available in 4 out of 5 cases. We found rare <i>IDH2</i> mutations in two cases, with <i>IDH2</i> R172W mutation in one case and <i>IDH2</i> R172K mutation in another case. Both cases had very small mutant peaks, suggesting that the tumor volume was low in the tumor samples. Thus, the specificity of MRS for detecting IDH1/2 mutations was higher (81.3%) than that originally reported (72.2%). The detection of 2HG by MRS can aid in the diagnosis of rare, non-IDH1-R132H <i>IDH1</i> and <i>IDH2</i> mutations in gliomas.Manabu NatsumedaHironaka IgarashiRamil GabdulkhaevHaruhiko TakahashiKunio MotohashiRyosuke OguraJun WatanabeYoshihiro TsukamotoKouichirou OkamotoAkiyoshi KakitaTsutomu NakadaYukihiko FujiiMDPI AGarticle2-hydroxyglutarategliomamagnetic resonance spectroscopyrare IDH mutationsfalse-positiveMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 2129, p 2129 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
2-hydroxyglutarate glioma magnetic resonance spectroscopy rare IDH mutations false-positive Medicine (General) R5-920 |
spellingShingle |
2-hydroxyglutarate glioma magnetic resonance spectroscopy rare IDH mutations false-positive Medicine (General) R5-920 Manabu Natsumeda Hironaka Igarashi Ramil Gabdulkhaev Haruhiko Takahashi Kunio Motohashi Ryosuke Ogura Jun Watanabe Yoshihiro Tsukamoto Kouichirou Okamoto Akiyoshi Kakita Tsutomu Nakada Yukihiko Fujii Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases |
description |
We have previously published a study on the reliable detection of 2-hydroxyglutarate (2HG) in lower-grade gliomas by magnetic resonance spectroscopy (MRS). In this short article, we re-evaluated five glioma cases originally assessed as isocitrate dehydrogenase (IDH) wildtype, which showed a high accumulation of 2HG, and were thought to be false-positives. A new primer was used for the detection of <i>IDH2</i> mutation by Sanger sequencing. Adequate tissue for DNA analysis was available in 4 out of 5 cases. We found rare <i>IDH2</i> mutations in two cases, with <i>IDH2</i> R172W mutation in one case and <i>IDH2</i> R172K mutation in another case. Both cases had very small mutant peaks, suggesting that the tumor volume was low in the tumor samples. Thus, the specificity of MRS for detecting IDH1/2 mutations was higher (81.3%) than that originally reported (72.2%). The detection of 2HG by MRS can aid in the diagnosis of rare, non-IDH1-R132H <i>IDH1</i> and <i>IDH2</i> mutations in gliomas. |
format |
article |
author |
Manabu Natsumeda Hironaka Igarashi Ramil Gabdulkhaev Haruhiko Takahashi Kunio Motohashi Ryosuke Ogura Jun Watanabe Yoshihiro Tsukamoto Kouichirou Okamoto Akiyoshi Kakita Tsutomu Nakada Yukihiko Fujii |
author_facet |
Manabu Natsumeda Hironaka Igarashi Ramil Gabdulkhaev Haruhiko Takahashi Kunio Motohashi Ryosuke Ogura Jun Watanabe Yoshihiro Tsukamoto Kouichirou Okamoto Akiyoshi Kakita Tsutomu Nakada Yukihiko Fujii |
author_sort |
Manabu Natsumeda |
title |
Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases |
title_short |
Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases |
title_full |
Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases |
title_fullStr |
Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases |
title_full_unstemmed |
Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases |
title_sort |
detection of 2-hydroxyglutarate by 3.0-tesla magnetic resonance spectroscopy in gliomas with rare idh mutations: making sense of “false-positive” cases |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/02c8ce6392cb47eda48b441c0572e5df |
work_keys_str_mv |
AT manabunatsumeda detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases AT hironakaigarashi detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases AT ramilgabdulkhaev detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases AT haruhikotakahashi detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases AT kuniomotohashi detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases AT ryosukeogura detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases AT junwatanabe detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases AT yoshihirotsukamoto detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases AT kouichirouokamoto detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases AT akiyoshikakita detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases AT tsutomunakada detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases AT yukihikofujii detectionof2hydroxyglutarateby30teslamagneticresonancespectroscopyingliomaswithrareidhmutationsmakingsenseoffalsepositivecases |
_version_ |
1718412449479131136 |